Liebman, M



SignUp
(to Register)

Login
User Name
Password

Forgot Password?

Michael Liebman, Windber Research Institute
Michael N. Liebman, Ph.D. is executive Director of the Windber Research Institute after serving as Chief Scientific Officer since November, 2003. Prior to this he was Director, Computational Biology and Biomedical Informatics at the Abramson Family Cancer Research Institute of the University of Pennsylvania Cancer Center since September, 2000. He previously was Global Head of Computational Genomics at Roche Pharmaceuticals and Director, Bioinformatics and Pharmacogenomics at Wyeth Pharmaceuticals. He was also Director of Genomics for Vysis, Inc and Director of Bioinformatics at the Amoco Technology Company. He has served on the faculty of Mount Sinai School of Medicine in Pharmacology and Physiology/Bipohysics. He serves on 12 international scientific advisory boards, consults for 5 pharma/biotech companies and has been on the economic development programs in the Philadelphia Life Sciences Sector and the State of Illinois Biotechnology Commission. He is currently Chair of the Healthcare Task Force for the SMART program, and on the Human Health and Medicinal Chemistry Commission of the IUPAC. His research focuses on computational models of disease progression stressing riskdetection, disease process modeling and analysis of lifestyle interactions.
Abstract
News and Announcements
Featured Panel Discussion
Personalised Medicine: Safety and Efficacy Concerns Discussed as a Case Study
Drug Discovery Workshop
Oxford, 20-24 July 2009
Hyderabad, 7-10 Dec 2009
InnovationWell Workshop
ICT & KM Support Systems for R&D
Philadelphia, 13 October 2008
InterAction Meetings 2008
Innovation in Life Science & Healthcare Research & Product Developement
Philadelphia, 14-17 October 2008
Knowledge Management Training
Certified Knowledge Manager,
4-8 May 2009
» Download Training Program Brochure
Virtual Proceedings for Members
» Integrating Knowledge in the Life Science Product Life Cycle
» Drug Safety Knowledge Management
Featured Talks for Visitors
Knowledge Management in Drug Safety - Sidney N Kahn, PvRM
Building the Drug Safety Body of Knowledge - Jim Averback, LSIP
The Ferryman Blog
KM & Community news
Sponsors

Colayer 2.2 © Copyright 2004-2007 Colayer 
Colayer